ÂÜÀòÂÒÂ×

David Skibinski, PhD PMP, currently serves as the Director of Immunology at Curevo Vaccine since June 2023. With extensive experience in the field, David has previously held the position of Principal Scientist in Immunology Services at Nexelis from September 2020 to June 2023, where responsibilities included leading assay development and directing automated data processing pipelines. Earlier roles include Staff Scientist at Benaroya Research Institute, Principal Scientist at Merck, Research Scientist at A*STAR, Laboratory Head at Novartis Vaccines, and Research Scientist at Chiron Corporation. David's educational background includes a PhD in Molecular Biology and Microbial Physiology from The University of Sheffield and a BSc (Hons) in Microbiology and Virology from the University of Warwick. Contributions to the field include significant publications and advancements in vaccine and biomarker research across various organizations.